subject: UMLS:C1145204


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED

object_name: Carcinoma of the prostate stage III

tested_intervention: unsure


subject: UMLS:C1145204

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C1145204

object_name: Stage I Prostate Cancer AJCC v6


subject: UMLS:C1145204

object_name: Prostate cancer stage I


subject: UMLS:C1145204

object_name: Stage I Prostate Cancer AJCC v8


subject: UMLS:C1145204

object_name: Stage I Prostate Cancer AJCC v7


subject: UMLS:C1145204

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UMLS:C1145204

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UMLS:C1145204

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C1145204

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C1145204

object_name: prostate adenocarcinoma


subject: CHEBI:63633

subject_name: Triptorelin

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:63633

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: UMLS:C0112708


subject: CHEBI:31824

subject_name: Mesna

object_name: Pleural effusion


subject: CHEBI:31824

object_name: Pleural Effusion, CTCAE


subject: CHEBI:31824

object_name: x-ray of chest: pleural effusion


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: PUBCHEM.COMPOUND:9815560

subject_name: Estreptoquinasa


subject: PUBCHEM.COMPOUND:9815560


subject: PUBCHEM.COMPOUND:9815560


subject: UNII:8X1OXL3SNU

subject_name: STREPTOKINASE


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UMLS:C0038418

subject_name: streptokinase


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UNII:DO94E28WYW

object_name: liver carcinoma


subject: UNII:DO94E28WYW

object_name: liver cancer


subject: CHEMBL.COMPOUND:CHEMBL4650418


subject: CHEMBL.COMPOUND:CHEMBL4650418


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: CHEBI:78825

subject_name: Avutometinib

object_name: diffuse glioma, H3 G34 mutant


subject: CHEBI:78825

object_name: glioblastoma


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C4045781

object_name: renal cell carcinoma

tested_intervention: yes


subject: UMLS:C4045781

object_name: kidney neoplasm


subject: UMLS:C4045781

object_name: kidney cancer


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:64153

object_name: non-Hodgkin lymphoma


subject: CHEBI:64153

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:64153

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Dry Eye, CTCAE


subject: CHEBI:74705

object_name: Dryness of eye


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C1328695

subject_name: silicon phthalocyanine 4

object_name: precancerous condition


subject: UMLS:C0906802

object_name: disseminated eosinophilic collagen disease


subject: UMLS:C0906802

object_name: Eosinophilia


subject: UMLS:C0906802

object_name: idiopathic hypereosinophilic syndrome


subject: UMLS:C0906802

object_name: myeloproliferative neoplasm


subject: CHEBI:8378

subject_name: Prednisolone

object_name: myocarditis


subject: PUBCHEM.COMPOUND:9811567

subject_name: Advair

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:9811567

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: Wound Infection


subject: PUBCHEM.COMPOUND:3467

object_name: Wound Infection, CTCAE


subject: PUBCHEM.COMPOUND:3467

object_name: Wounds and Injuries


subject: PUBCHEM.COMPOUND:3467

object_name: Burn injury


subject: PUBCHEM.COMPOUND:3467

object_name: Burns and Wounds


subject: CHEBI:114785

subject_name: Erlotinib

object_name: metastatic colorectal cancer


subject: CHEBI:16899

subject_name: Mannitol

object_name: prostate carcinoma


subject: CHEBI:16899

object_name: prostate cancer


subject: UMLS:C0939788

subject_name: Zometa

object_name: prostate neoplasm


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Alzheimer disease


subject: CHEBI:134716

object_name: nervous system disorder


subject: CHEBI:7466

subject_name: Nandrolone

object_name: malnutrition


subject: CHEBI:7466

object_name: Critical Illness


subject: UMLS:C0002845

subject_name: Androgens, Synthetic


subject: UMLS:C0002845


subject: UMLS:C5671313

subject_name: Anabolic Androgenic Steroids


subject: UMLS:C5671313


subject: CHEBI:178199

subject_name: Sotorasib


subject: CHEBI:9241

subject_name: Spironolactone

object_name: acne


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: premature ejaculation


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UMLS:C0499161

object_name: non-small cell lung carcinoma


subject: UMLS:C5235658

subject_name: Targeted Therapy Agent


subject: UMLS:C5235658


subject: CHEBI:145371

subject_name: Binimetinib

object_name: colorectal carcinoma


subject: CHEBI:145371

object_name: lung adenocarcinoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: peripheral vascular disease


subject: CHEBI:68579

object_name: peripheral arterial disease


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: Glaucoma, Suspect


subject: UNII:SXN0KXT60S

object_name: HIV-1 infection


subject: UNII:SXN0KXT60S

object_name: HIV infection


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: cocaine dependence


subject: UNII:6X58GJ0RMS

object_name: malaria


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Coronavinae infectious disease


subject: UNII:2CQ8Y0B8XQ

object_name: rheumatoid arthritis


subject: UMLS:C5544272

object_name: COVID-19 respiratory infection


subject: UMLS:C5544272

object_name: long COVID-19


subject: CHEBI:17252

subject_name: Hydroxyprogesterone

object_name: Premature birth


subject: CHEBI:17252

object_name: transvaginal ultrasound: length of cervix


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: acute coronary syndrome


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: CHEBI:135207

subject_name: Clofedanol


subject: PR:000004321

subject_name: arylsulfatase A


subject: CHEBI:50438

subject_name: Phenprocoumon


subject: CHEBI:50438

object_name: atrial fibrillation


subject: CHEBI:50438

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:50438

object_name: Atrial Fibrillation, CTCAE


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Advanced HER2-Negative Breast Carcinoma


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:135918

subject_name: Tucidinostat


subject: UMLS:C1176021

object_name: prostate cancer


subject: UMLS:C1176021

object_name: prostate neoplasm


subject: CHEBI:7009

subject_name: Moxonidine

object_name: Irritable heart


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hyperactive delirium


subject: CHEBI:4466

object_name: Delirium of Mixed Origin


subject: UNII:JD5ZWE631K

object_name: pulmonary fibrosis


subject: UNII:JD5ZWE631K

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:5558

subject_name: Guanfacine

object_name: Cannabis use disorder


subject: CHEBI:63631

subject_name: Topiramate

object_name: Parkinson disease


subject: CHEMBL.COMPOUND:CHEMBL5315069

subject_name: DAMOCTOCOG ALFA PEGOL

object_name: hemophilia A


subject: UMLS:C4723219

subject_name: damoctocog alfa pegol


subject: UMLS:C4723224

subject_name: Jivi


subject: MESH:C419427

subject_name: polysaccharide MGN3

object_name: liver carcinoma


subject: MESH:C419427

object_name: hepatitis B


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: CNS metastases


subject: UMLS:C3827082


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Post-Dural Puncture Headaches


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:201491

subject_name: Amoxicillin Clavulanate

object_name: Thyroid nodule


subject: CHEBI:201491

object_name: nodule of thyroid by palpation


subject: CHEBI:201491

object_name: Surgical Wound Infection


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: UMLS:C0054066


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Kidney graft dysfunction


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:9168

subject_name: Sirolimus


subject: UMLS:C5555006

object_name: pancreatic neoplasm


subject: UMLS:C5555006

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5555006

object_name: malignant pancreatic neoplasm


subject: CHEBI:231350

subject_name: Pacritinib


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C0379528

object_name: Rectal cancer stage IV


subject: UMLS:C0379528

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C0379528

object_name: Recurrent Rectal Cancer


subject: UMLS:C0379528

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C0379528

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C0379528

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C0379528

object_name: Colon cancer recurrent


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Effects of chemotherapy


subject: CHEBI:73611

subject_name: Met-Gly


subject: CHEBI:73611


subject: CHEBI:73611


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:16349

subject_name: Citrulline

object_name: Hypoperfusion


subject: CHEBI:16349

object_name: Adverse Event Associated with the Gastrointestinal System


subject: CHEBI:16349

object_name: Digestive System Finding


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: proteinuria


subject: UMLS:C1145201

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C1145201

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C1145201

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C1145201

object_name: Fabry disease


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:132922

object_name: cystic fibrosis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:4757

object_name: Infection


subject: CHEBI:4757

object_name: infectious disease


subject: CHEBI:4757

object_name: Adverse Event Associated with Infection


subject: CHEBI:4757

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:4757

object_name: lymphoproliferative syndrome


subject: CHEBI:4757

object_name: myeloproliferative neoplasm


subject: CHEBI:4757


subject: CHEBI:4757

object_name: Myelodysplasia


subject: CHEBI:4757

object_name: leukemia


subject: CHEBI:4757

object_name: childhood leukemia


subject: CHEBI:4757

object_name: adult lymphoma


subject: CHEBI:4757

object_name: lymphoma


subject: CHEBI:4757

object_name: pediatric lymphoma


subject: CHEBI:4735

subject_name: Edetic acid


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:4735


subject: UMLS:C3854029

subject_name: antiseptics ethanol


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C1441101

subject_name: Polio virus 3 (antigen)

object_name: poliomyelitis


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: precancerous condition


subject: CHEBI:75832


subject: CHEBI:75832


subject: CHEBI:75832


subject: CHEBI:75832


subject: CHEBI:75832


subject: CHEBI:75832


subject: CHEBI:75832


subject: UMLS:C2222706

subject_name: sodium ferric gluconate complex in sucrose

object_name: anemia


subject: UMLS:C2222706

object_name: Anemia, CTCAE


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: UMLS:C2222706


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: adult acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108387

subject_name: LANOLIN

object_name: Breastfeeding (mother)


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Postoperative ileus


subject: UNII:7VJU9PSU87

object_name: Congenital IGHD


subject: UNII:7VJU9PSU87

object_name: Reduced circulating growth hormone concentration


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: Malignant melanoma of skin of breast


subject: UMLS:C2745354

object_name: mucopolysaccharidosis type 1


subject: CHEBI:201491

subject_name: Amoxicillin Clavulanate

object_name: Device related infection


subject: CHEBI:201491

object_name: prosthesis-related infectious disease


subject: CHEBI:201491

object_name: Device Related Infection, CTCAE


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: UMLS:C0054066


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: sickle cell disease


subject: CHEBI:124959

subject_name: Tilarginine


subject: UMLS:C0069477


subject: PUBCHEM.COMPOUND:3417

object_name: Antibiotic resistant infection


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: PUBCHEM.COMPOUND:134129840

subject_name: POLYMYXIN B


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEBI:142708


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: dyspepsia


subject: UMLS:C3819106

object_name: Dyspepsia, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: sarcopenia


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: UMLS:C0242896

subject_name: Anticholinergic Agents

object_name: Urinary Urgency


subject: UMLS:C0242896

object_name: lower urinary tract symptom


subject: UMLS:C0242896

object_name: Presenile dementia


subject: UMLS:C0242896

object_name: dementia


subject: UMLS:C0242896

object_name: urgency urinary incontinence


subject: UMLS:C3537004

subject_name: Anticholinergic [EPC]


subject: UMLS:C3537004


subject: UMLS:C3537004


subject: UMLS:C3537004


subject: UMLS:C3537004


subject: UMLS:C0001637

subject_name: Adrenergic Agents


subject: UMLS:C0001637


subject: UMLS:C0001637


subject: UMLS:C0001637


subject: UMLS:C4541385

subject_name: Heplisav-B

object_name: Pregnant


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: methamphetamine dependence


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Non-small cell lung cancer stage III


subject: UMLS:C4053601


subject: UMLS:C3896750

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Breast cancer stage II


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Breast Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Breast Carcinoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348

object_name: endometrial cancer


subject: CHEBI:31348

object_name: uterine corpus cancer


subject: CHEBI:31348

object_name: endometrial carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355

object_name: biliary tract cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan


subject: GTOPDB:13304

object_name: Stomach cancer


subject: GTOPDB:13304

object_name: gastric cancer


subject: GTOPDB:13304

object_name: ovarian cancer


subject: GTOPDB:13304

object_name: ovarian neoplasm


subject: GTOPDB:13304

object_name: ovarian carcinoma


subject: GTOPDB:13304


subject: GTOPDB:13304

object_name: colorectal cancer


subject: GTOPDB:13304

object_name: colorectal carcinoma


subject: GTOPDB:13304

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304


subject: GTOPDB:13304

object_name: liver carcinoma


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: UMLS:C5417881

subject_name: Volrustomig


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Mantle cell lymphoma refractory


subject: CHEBI:90942

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:456215

subject_name: adenosine 5'-monophosphate(2-)

object_name: osteoarthritis, knee


subject: CHEBI:28931


subject: PUBCHEM.COMPOUND:53481006

subject_name: Adenosine 2'-phosphate


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:40050

subject_name: Amprenavir


subject: UMLS:C4084937

subject_name: Antimicrobial Peptide


subject: UMLS:C4285220

subject_name: Absorbable Modified Polymer Hemostatic Powder


subject: PUBCHEM.COMPOUND:156963740

subject_name: Dasiglucagon

object_name: glucose metabolism disease


subject: CHEBI:2637

subject_name: Amikacin

object_name: Febrile Neutropenia


subject: CHEBI:2637

object_name: Febrile Neutropenia, CTCAE


subject: CHEBI:478164

subject_name: Cefepime


subject: UMLS:C5445193

subject_name: Ceftazidime Liquid Injection


subject: UMLS:C5445193


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: UNII:X00B0D5O0E


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: UMLS:C4048697

subject_name: Vancomycin Liquid Injection


subject: UMLS:C4048697


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: PUBCHEM.COMPOUND:6321415


subject: CHEBI:28487

subject_name: Reserpine

object_name: Blood pressure increased refractory


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: complete trisomy 21


subject: CHEBI:6887

object_name: Down syndrome


subject: MESH:C586502

subject_name: tegafur-gimeracil-oteracil

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: MESH:C586502

object_name: stage IV pancreatic cancer


subject: MESH:C586502

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:31562

subject_name: estramustine sodium phosphate

object_name: prostate carcinoma


subject: CHEBI:31562

object_name: prostate cancer


subject: UNII:75F375MT2N

subject_name: Estramustine Phosphate Sodium Hydrate


subject: UNII:75F375MT2N


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Malaria, Vivax


subject: CHEBI:15611

subject_name: Sarcosine

object_name: schizophrenia


subject: UMLS:C0036228

subject_name: sarcosine


subject: CHEBI:30502


subject: CHEBI:30501

subject_name: beryllium atom


subject: PR:000035348

subject_name: 1,4-alpha-glucan branching enzyme GlgB


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: pulmonary hypertension


subject: CHEBI:15552

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C4080995

subject_name: Dyanavel XR

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C4080995


subject: UMLS:C4080995

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C4080995

object_name: Fatigue


subject: UMLS:C1705207

subject_name: Endostar

object_name: Childhood Neuroblastoma


subject: UMLS:C1705207

object_name: neuroblastoma


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: asthma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: invasive lobular breast carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: invasive ductal breast carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: breast ductal adenocarcinoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C5417810

subject_name: CDK4/6 Inhibitor HS-10342

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:L63605PZ70

subject_name: TALAPORFIN SODIUM

object_name: liver carcinoma


subject: UMLS:C1312955

subject_name: talaporfin sodium


subject: CHEBI:135875

subject_name: Talaporfin


subject: UMLS:C5690696

subject_name: MitoQ

object_name: chronic obstructive pulmonary disease


subject: DRUGBANK:DB16979

subject_name: Spheramine

object_name: Parkinson disease


subject: UMLS:C0304402

subject_name: Stimulant

object_name: Atypical behavior


subject: UMLS:C3536952

subject_name: Central Nervous System Stimulant [EPC]


subject: CHEBI:71013

subject_name: Perampanel

object_name: primary brain neoplasm


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: carcinoma of biliary tract


subject: UMLS:C1831855

object_name: carcinoma


subject: UMLS:C1831855

object_name: Neoplasm Metastasis


subject: UMLS:C1831855

object_name: liver neoplasm


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: pediatric osteosarcoma


subject: CHEBI:50223

object_name: Osteosarcoma


subject: CHEBI:50223

object_name: Secondary malignant neoplasm of lung


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:31623

subject_name: Fluocinolone acetonide

object_name: posterior uveitis


subject: CHEBI:31623

object_name: anterior uveitis


subject: CHEBI:31623

object_name: intermediate uveitis


subject: CHEBI:31623

object_name: uveitis


subject: CHEBI:31623

object_name: Uveitis, CTCAE


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:175901

object_name: rhabdomyosarcoma


subject: CHEBI:175901

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:175901

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:175901

object_name: Ewing sarcoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255

object_name: Childhood Soft Tissue Sarcoma


subject: MESH:C520255

object_name: Adult Soft Tissue Sarcoma


subject: MESH:C520255

object_name: sarcoma


subject: MESH:C520255

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: MESH:C520255

object_name: soft tissue sarcoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: pediatric osteosarcoma


subject: CHEBI:45863

object_name: Osteosarcoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C1831824

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C1831824

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C1831824

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C1831824

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C1831824

object_name: prostate adenocarcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: septic shock


subject: CHEBI:82975

subject_name: Naloxegol

object_name: Critical Illness


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: Sexual Health


subject: CHEBI:172705

subject_name: DEHYDROSILYLBIN

object_name: hepatitis C


subject: UNII:4RKY41TBTF

subject_name: SILIBININ


subject: UMLS:C5707910

subject_name: Rhenium (186-Re) obisbemeda

object_name: neoplastic meningitis


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:11227182

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:2950

subject_name: Azelastine

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:44915

subject_name: Propofol

object_name: inflammatory bowel disease


subject: GTOPDB:4985

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: GTOPDB:4985

object_name: amyotrophic lateral sclerosis


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UNII:K1WT1A1UP5

object_name: Neck Carcinoma


subject: UNII:K1WT1A1UP5

object_name: head and neck neoplasm


subject: UNII:K1WT1A1UP5

object_name: head and neck cancer


subject: UNII:K1WT1A1UP5

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:K1WT1A1UP5

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:K1WT1A1UP5

object_name: Adult Solid Neoplasm


subject: UNII:K1WT1A1UP5

object_name: head and neck squamous cell carcinoma


subject: UNII:K1WT1A1UP5

object_name: colorectal adenocarcinoma


subject: UNII:D07V79Q44T

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:D07V79Q44T

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:D07V79Q44T

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:D07V79Q44T

object_name: neoplasm


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Age-related sarcopenia


subject: CHEBI:9168

object_name: Muscle Atrophy


subject: PUBCHEM.COMPOUND:128795

object_name: hemiplegia


subject: CHEBI:167099


subject: PR:000001968

subject_name: tyrosine-protein phosphatase non-receptor type substrate 1


subject: GTOPDB:11649

subject_name: feladilimab


subject: UNII:OUP4QB2A3R

subject_name: FELADILIMAB


subject: UMLS:C4287758

subject_name: Feladilimab


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: mucositis


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: low grade glioma


subject: CHEBI:93786


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Cerebral Vasospasm


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:4672

subject_name: Docetaxel


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: Childhood Solid Neoplasm


subject: MESH:D000082082

object_name: Solid Neoplasm


subject: MESH:D000082082

object_name: Neck Carcinoma


subject: MESH:D000082082

object_name: head and neck neoplasm


subject: MESH:D000082082

object_name: head and neck cancer


subject: MESH:D000082082

object_name: female reproductive organ cancer


subject: MESH:D000082082

object_name: skin neoplasm


subject: MESH:D000082082

object_name: skin cancer


subject: MESH:D000082082

object_name: pancreatic neoplasm


subject: MESH:D000082082

object_name: exocrine pancreatic carcinoma


subject: MESH:D000082082

object_name: malignant pancreatic neoplasm


subject: MESH:D000082082

object_name: renal carcinoma


subject: MESH:D000082082

object_name: kidney neoplasm


subject: MESH:D000082082

object_name: kidney cancer


subject: UMLS:C3658854

object_name: dermatitis


subject: UMLS:C3658854

object_name: Eczema, CTCAE


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: chronic hepatitis B virus infection


subject: CHEBI:8228

object_name: Liver Fibrosis


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: prostate carcinoma


subject: UMLS:C0812735

object_name: prostate cancer


subject: UMLS:C0812735

object_name: endometriosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: UMLS:C3252109

subject_name: TAK 385


subject: UMLS:C3252109


subject: CHEBI:15365

subject_name: Aspirin

object_name: Non-allergic anaphylaxis caused by non steroidal anti-inflammatory drug


subject: CHEBI:15365

object_name: NSAID-induced angioedema-urticaria


subject: CHEBI:15365

object_name: Aspirin exacerbated respiratory disease


subject: CHEBI:15365

object_name: Non-allergic anaphylaxis caused by aspirin


subject: CHEBI:15365

object_name: Aspirin-induced angioedema-urticaria


subject: CHEBI:15365

object_name: aspirin allergy


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: aspirin sensitivity


subject: CHEBI:35475


subject: CHEBI:35475


subject: CHEBI:35475


subject: CHEBI:35475


subject: CHEBI:35475


subject: CHEBI:35475

object_name: Aspirin-induced asthma


subject: CHEBI:35475


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: UMLS:C0358845


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C5401611

subject_name: Washed Microbiota Transplantation

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C1169989

subject_name: buprenorphine / naloxone

object_name: HIV infection


subject: RXCUI:352990

subject_name: Suboxone


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: celiac disease


subject: DRUGBANK:DB19249

object_name: Non-celiac gluten sensitivity


subject: DRUGBANK:DB19249

object_name: Gluten intolerance


subject: DRUGBANK:DB19249

object_name: History of gluten sensitivity


subject: CHEBI:23965

subject_name: estradiol

object_name: Postmenopausal symptoms


subject: UMLS:C4270999

subject_name: NETSPOT

object_name: head and neck squamous cell carcinoma


subject: UNII:Y68179SY2L


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: lymphoproliferative syndrome


subject: UNII:52CMI0WC3Y

object_name: Neoplasms by Histologic Type


subject: UNII:52CMI0WC3Y

object_name: Primary malignant neoplasm


subject: UNII:52CMI0WC3Y

object_name: Malignant obstetric neoplasm


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: multiple sclerosis


subject: CHEBI:127342

object_name: Memory Disorders


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin

object_name: female infertility


subject: UMLS:C0025326

subject_name: Menotropins


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: maturity-onset diabetes of the young type 3


subject: CHEBI:31797

subject_name: Gadolinium DTPA

object_name: Meniere disease


subject: CHEBI:180856

subject_name: Hovenoside G


subject: UMLS:C0721529

subject_name: Magnevist


subject: CHEBI:59549

subject_name: essential fatty acid

object_name: schizophrenia


subject: MESH:D005228

subject_name: Fatty Acids, Essential


subject: UNII:3JGY52XJNA

subject_name: Lutropin alfa

object_name: Poor response to ovulation induction


subject: UMLS:C5448047

subject_name: STP 705

object_name: Bowen's Disease


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Neoplasm Metastasis


subject: CHEBI:93786


subject: CHEBI:91400

subject_name: Afatinib


subject: UMLS:C5564916

subject_name: VB10.2129 vaccine


subject: UMLS:C5564916

object_name: Infection


subject: UMLS:C5564916

object_name: Infection of musculoskeletal system


subject: UMLS:C5564916

object_name: viral disease


subject: UMLS:C5564915

subject_name: VB10.2210 vaccine


subject: UMLS:C5564915


subject: UMLS:C5564915


subject: UMLS:C5564915


subject: UMLS:C0056562

subject_name: crystalloid solutions

object_name: kidney failure


subject: UMLS:C0681579

subject_name: Vitamin supplement

object_name: neuroendocrine neoplasm


subject: UMLS:C0681579

object_name: APUdoma


subject: UMLS:C0540110

subject_name: HOE 901

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0540110

object_name: type 1 diabetes mellitus


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: migraine


subject: MESH:C000656584

object_name: inner ear disorder


subject: UMLS:C1328728

object_name: liver carcinoma


subject: CHEBI:39585

subject_name: Carbidopa

object_name: alcohol abuse


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0392939

object_name: acute myeloid leukemia


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0919144

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0919144

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0919144


subject: UMLS:C0919144

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UMLS:C5555758

subject_name: Indium In 111-DOTA-Basiliximab

object_name: Myelodysplasia


subject: UMLS:C5555758


subject: UMLS:C5555758


subject: UMLS:C5555758


subject: UMLS:C5555758

object_name: acute lymphoblastic leukemia


subject: UMLS:C5555758


subject: UMLS:C5555758


subject: UMLS:C5555758


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: UMLS:C3274580

subject_name: Yttrium Y 90 Basiliximab


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: CHEBI:74557

subject_name: Lys-Glu

object_name: Right ventricular diastolic dysfunction


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Neoplasm Metastasis


subject: GTOPDB:4934

object_name: colorectal neoplasm


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:191174

object_name: breast carcinoma


subject: CHEBI:191174

object_name: breast cancer


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: UNII:820NH671E6

subject_name: Prexasertib


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: bipolar disorder


subject: UMLS:C0886352

subject_name: wild thyme extract

object_name: functional gastric disease


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: Small cell lung cancer extensive stage


subject: CHEBI:16348

subject_name: Bovinocidin

object_name: hypertension


subject: CHEBI:16348

object_name: Hypertension, CTCAE


subject: CHEBI:80234

subject_name: Brain natriuretic peptide


subject: CHEBI:80234


subject: PUBCHEM.COMPOUND:6026

subject_name: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg


subject: PUBCHEM.COMPOUND:6026


subject: CHEBI:3165

subject_name: Bradykinin


subject: CHEBI:3165


subject: CHEBI:132988


subject: CHEBI:132988


subject: UNII:S8TIM42R2W

subject_name: BRADYKININ


subject: UNII:S8TIM42R2W


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:190692

subject_name: substance P(3+)


subject: CHEBI:190692


subject: CHEBI:80308

subject_name: substance P


subject: CHEBI:80308


subject: UNII:675VGV5J1D

subject_name: SUBSTANCE P


subject: UNII:675VGV5J1D


subject: UMLS:C0038585

subject_name: Substance P


subject: UMLS:C0038585


subject: UNII:64J9J55263

subject_name: Tezosentan

object_name: pulmonary hypertension, primary, 1


subject: UNII:64J9J55263

object_name: pulmonary hypertension


subject: UNII:64J9J55263

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:64J9J55263

object_name: pulmonary arterial hypertension


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: chronic granulomatous disease


subject: CHEBI:71200

object_name: Inflammatory lung disease


subject: CHEBI:71200

object_name: inflammatory skin disease


subject: CHEBI:71200

object_name: dermatitis


subject: CHEBI:71200

object_name: Dermatitis


subject: CHEBI:71219

subject_name: Pazopanib

object_name: macular degeneration


subject: CHEBI:71219

object_name: age-related macular degeneration


subject: CHEBI:71219

object_name: retinitis pigmentosa 30


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: neuralgia


subject: CHEBI:5790

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: brain injury


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3827091


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: hepatitis C


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: GTOPDB:12517

subject_name: tafolecimab

object_name: acute coronary syndrome


subject: GTOPDB:12517

object_name: Non ST segment elevation acute coronary syndrome


subject: CHEMBL.COMPOUND:CHEMBL4594554

subject_name: TAFOLECIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594554


subject: UMLS:C5419329

subject_name: Tafolecimab


subject: UMLS:C5419329


subject: CHEMBL.COMPOUND:CHEMBL2109337

object_name: rheumatoid arthritis


subject: UMLS:C2346795

subject_name: MDX-1342 antibody


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: BRAF V600E mutation positive


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:50169

subject_name: Brexanolone

object_name: acute respiratory distress syndrome


subject: CHEBI:50169

object_name: adult acute respiratory distress syndrome


subject: CHEBI:50169


subject: CHEBI:135207

subject_name: Clofedanol

object_name: digestive system cancer


subject: CHEBI:15365

subject_name: Aspirin


subject: UNII:NX3NW9MM9W

subject_name: VISUGROMAB

object_name: bladder tumor


subject: UNII:NX3NW9MM9W

object_name: urinary bladder carcinoma


subject: UNII:NX3NW9MM9W

object_name: urinary bladder cancer


subject: UNII:NX3NW9MM9W

object_name: childhood bladder carcinoma


subject: UMLS:C5555769

subject_name: Visugromab


subject: UMLS:C5555769


subject: UMLS:C5555769


subject: UMLS:C5555769


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: portal vein thrombosis


subject: CHEBI:3641

object_name: Portal Vein Thrombosis, CTCAE


subject: UMLS:C0723595

subject_name: Tace


subject: UMLS:C0723595


subject: UMLS:C2364019

object_name: Kaposi Sarcoma


subject: UMLS:C2364019

object_name: HIV infection


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: primary central nervous system lymphoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic carcinoma stage II


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:44915

subject_name: Propofol

object_name: prostate carcinoma


subject: CHEBI:44915

object_name: prostate cancer


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: Polypoidal choroidal vasculopathy


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Small cell lung cancer limited stage


subject: CHEBI:585948

subject_name: Felodipine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:585948

object_name: obesity


subject: CHEBI:585948

object_name: Obesity, CTCAE


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEBI:8774


subject: CHEBI:8774


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: hypertension


subject: UNII:889I657R9P

object_name: Hypertension, CTCAE


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: UNII:987R943R3P


subject: CHEBI:9137

subject_name: Sibutramine


subject: CHEBI:9137


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:9649

subject_name: Trandolapril


subject: CHEBI:9649


subject: CHEBI:9649


subject: PUBCHEM.COMPOUND:4689

subject_name: Paromomycin I

object_name: cutaneous leishmaniasis


subject: CHEBI:233202


subject: CHEBI:7934

subject_name: Paromomycin


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: Hodgkin Disease


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: Adult Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297702

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C2698151


subject: UMLS:C2698151


subject: UMLS:C2698151


subject: UMLS:C2698151


subject: UMLS:C2698151


subject: UMLS:C2698151


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: meningitis


subject: UMLS:C0812735

object_name: Meningitis, CTCAE


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Iron deficiency anemia of pregnancy


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: CHEBI:75832

subject_name: ferrous sulfate


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:15633

subject_name: dihydrofolate


subject: CHEBI:176842

subject_name: vitamin B9


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Central pain syndrome


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Intracranial glioma


subject: UNII:DPT0O3T46P

object_name: Glioblastoma by Gene Expression Profile


subject: CHEBI:47426

subject_name: Furosemide

object_name: acute kidney failure


subject: CHEBI:47426

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:8405

subject_name: Primaquine

object_name: Malaria relapse


subject: CHEBI:135752

subject_name: Tafenoquine


subject: UMLS:C5555017

subject_name: Anti-PSMA Antibody-drug Conjugate ARX517

object_name: metastatic prostate carcinoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: schizoaffective disorder


subject: UMLS:C1527137

object_name: schizophrenia 18


subject: UMLS:C1527137

object_name: major affective disorder 4


subject: UMLS:C1527137

object_name: major affective disorder 7


subject: UMLS:C1527137

object_name: bipolar disorder


subject: UMLS:C1527137

object_name: major affective disorder 6


subject: UMLS:C1527137

object_name: major affective disorder 2


subject: UMLS:C1527137

object_name: major affective disorder 8


subject: UMLS:C1527137

object_name: major affective disorder 9


subject: UMLS:C1527137

object_name: major affective disorder 1


subject: UMLS:C1527137

object_name: major affective disorder 5


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C2241157

subject_name: Theophylline ER

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C2241157

object_name: COPD, severe early onset


subject: UMLS:C2241157

object_name: chronic obstructive pulmonary disease


subject: UMLS:C2241157

object_name: pollution related respiratory disorder


subject: UMLS:C2241157

object_name: Exposure to pollution


subject: UMLS:C2241157

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: UMLS:C2241157

object_name: COPD exacerbation


subject: UMLS:C0762110

object_name: cardiac edema


subject: CHEBI:231425

subject_name: tolvaptan


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: colorectal neoplasm


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]


subject: UMLS:C5552784

subject_name: Therapeutic Autologous Platelet-rich Plasma

object_name: Genitourinary syndrome of menopause


subject: UMLS:C5552784

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C5552784

object_name: breast adenocarcinoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Control of hip fracture risk


subject: PUBCHEM.COMPOUND:92043599

object_name: hip fracture


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: UNII:6897GXD6OE


subject: UNII:6897GXD6OE


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: chronic gastritis


subject: CHEBI:51254

object_name: Stomach cancer


subject: CHEBI:51254

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:16118

subject_name: Berberine


subject: CHEBI:16118


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Helicobacter pylori infection


subject: CHEBI:8768


subject: CHEBI:8768


subject: CHEBI:8768


subject: CHEBI:8768

object_name: dyspepsia


subject: CHEBI:8768

object_name: Dyspepsia, CTCAE


subject: CHEBI:31215

subject_name: anecortave

object_name: open-angle glaucoma


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: Family history of ischemic heart disease


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: UMLS:C5873038

subject_name: Insulin Human (inhaled)

object_name: asthma


subject: UMLS:C5783941

subject_name: P2Y12 Inhibitor

object_name: myocardial infarction


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: alcohol abuse


subject: CHEBI:16581

object_name: alcohol dependence


subject: CHEBI:6801

subject_name: Metformin

object_name: cancer


subject: UMLS:C0147288

subject_name: Tyr(TMA)

object_name: Myocardial Reperfusion Injury


subject: CHEBI:24848

subject_name: inositol

object_name: anxiety disorder


subject: CHEBI:24848

object_name: bipolar disorder


subject: CHEBI:24848

object_name: anxiety


subject: CHEBI:24848

object_name: Anxiety symptoms


subject: CHEBI:24848

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:24848

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage III Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: adenoid cystic carcinoma


subject: CHEBI:63610

subject_name: Misoprostol

object_name: pregnancy related


subject: CHEBI:45863

object_name: Gastroesophageal junction cancer


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C5418026

subject_name: Osemitamab

object_name: Stomach cancer


subject: UMLS:C5418026

object_name: gastric cancer


subject: UMLS:C5418026

object_name: pancreatic neoplasm


subject: UMLS:C5418026

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5418026

object_name: malignant pancreatic neoplasm


subject: UMLS:C5418026

object_name: Advanced cancer


subject: UMLS:C5418026


subject: UMLS:C5555503

subject_name: Anti-CSF1R Monoclonal Antibody AMB-05X

object_name: interstitial lung disease 2


subject: UMLS:C5555503

object_name: pulmonary fibrosis


subject: UMLS:C5555503

object_name: idiopathic interstitial pneumonia


subject: CHEBI:45863

object_name: esophageal disorder


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C5557449

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5557449

object_name: Embolism, Tumor


subject: UMLS:C5557449

object_name: Neoplasm Metastasis


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: end stage renal failure


subject: UNII:Q91187K011

object_name: Chronic uremia


subject: UNII:Q91187K011

object_name: hyperphosphatemia


subject: UNII:Q91187K011

object_name: Serum phosphate concentrations above normal (finding)


subject: UNII:Q91187K011

object_name: Hyperphosphatemia, CTCAE


subject: CHEBI:144421

subject_name: ferric citrate


subject: CHEBI:144421


subject: CHEBI:144421


subject: CHEBI:144421


subject: CHEBI:144421


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: Recurrent Craniopharyngioma


subject: CHEBI:167672

object_name: Childhood Craniopharyngioma


subject: CHEBI:167672

object_name: craniopharyngioma


subject: CHEBI:167672

object_name: Adult Craniopharyngioma


subject: CHEBI:167672

object_name: Craniopharyngioma, Child


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: ADH increased


subject: CHEBI:15377

subject_name: Water


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:73151030

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:73151030

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:8707

subject_name: Quetiapine

object_name: combat disorder


subject: UMLS:C1320098

subject_name: Risperdal Consta

object_name: schizoaffective disorder


subject: UMLS:C1320098

object_name: schizophrenia 18


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C0077503

subject_name: Tumor Necrosis Factor Receptor

object_name: uveitis


subject: UMLS:C0077503

object_name: Uveitis, CTCAE


subject: UMLS:C0077503

object_name: juvenile idiopathic arthritis


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Hormone receptor negative HER2 positive breast cancer


subject: UMLS:C2703210

object_name: Childhood Breast Carcinoma


subject: UMLS:C2703210

object_name: breast carcinoma


subject: UMLS:C2703210

object_name: breast cancer


subject: UMLS:C2703210

object_name: hormone receptor-positive breast cancer


subject: UMLS:C2703210


subject: UNII:X9A7099R51

subject_name: Epzicom

object_name: HIV infection


subject: PUBCHEM.COMPOUND:73437646

subject_name: deutetrabenazine

object_name: Huntington disease


subject: UMLS:C0964361

subject_name: SonoVue

object_name: Carotid Artery Plaque


subject: UMLS:C0964361

object_name: arteriosclerosis disorder


subject: UMLS:C0964361

object_name: atherosclerosis


subject: UMLS:C0964361

object_name: Ischemic stroke


subject: CHEBI:30496

subject_name: Sulfur hexafluoride


subject: CHEBI:30496


subject: CHEBI:30496


subject: CHEBI:30496


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: cat-scratch disease


subject: UNII:78YP9ZU8U6

object_name: nonpapillary renal cell carcinoma


subject: UNII:78YP9ZU8U6

object_name: clear cell renal carcinoma


subject: UNII:78YP9ZU8U6

object_name: renal cell adenocarcinoma


subject: UNII:78YP9ZU8U6

object_name: renal cell carcinoma


subject: UNII:78YP9ZU8U6

object_name: lung cancer


subject: UNII:78YP9ZU8U6

object_name: lung neoplasm


subject: UNII:78YP9ZU8U6

object_name: lung carcinoma


subject: UNII:78YP9ZU8U6

object_name: Neck Carcinoma


subject: UNII:78YP9ZU8U6

object_name: head and neck neoplasm


subject: UNII:78YP9ZU8U6

object_name: head and neck cancer


subject: UNII:78YP9ZU8U6

object_name: liver carcinoma


subject: UNII:78YP9ZU8U6

object_name: squamous cell carcinoma


subject: UMLS:C2827672

subject_name: Fluorine F 18-VM4-037


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: UMLS:C2827672


subject: CHEBI:132967

subject_name: Elbasvir

object_name: Cross Infection


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: cancer


subject: CHEBI:91368

object_name: neoplasm


subject: UMLS:C1382107

subject_name: Suspension substance

object_name: Bilateral cataracts (disorder)


subject: UMLS:C1382107

object_name: cataract


subject: CHEBI:65415

subject_name: Antroquinonol

object_name: acute myeloid leukemia


subject: UNII:5X5HB3VZ3Z

subject_name: Apricoxib

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:4672

subject_name: Docetaxel

object_name: nasopharyngeal squamous cell carcinoma


subject: CHEBI:4672

object_name: Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: acute kidney failure


subject: CHEBI:4356

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:35526

subject_name: hypoglycemic agent

object_name: diabetic retinopathy


subject: UMLS:C0020616

subject_name: Hypoglycemic Agents


subject: UNII:MA10QYF1Z0

subject_name: Ferric maltol

object_name: pulmonary hypertension


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: neuralgia


subject: CHEBI:146178

object_name: Neuralgia, CTCAE


subject: CHEBI:146178

object_name: diabetic neuropathy


subject: CHEBI:146178

object_name: herpes zoster


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: UMLS:C0107153

subject_name: Brevicon

object_name: type 2 diabetes mellitus


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:149504

object_name: Diffuse myocardial fibrosis


subject: CHEBI:6541

subject_name: Losartan


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: arthritis


subject: UNII:FYS6T7F842

object_name: Arthritis, CTCAE


subject: CHEBI:27470

subject_name: Folic acid

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:27470

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: CHEBI:15365

subject_name: Aspirin

object_name: atrial septal defect, ostium secundum type


subject: CHEBI:15365

object_name: patent foramen ovale


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10033

object_name: Ischemic stroke


subject: UMLS:C5556487

subject_name: EGFR/CD3-targeting T-cell Engaging Molecule TAK-186

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: metastatic prostate carcinoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEBI:231678

subject_name: Evofosfamide


subject: CHEBI:231678

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:231678


subject: UNII:FE7L22H028

subject_name: ZALIFRELIMAB


subject: UNII:FE7L22H028


subject: UNII:FE7L22H028


subject: UMLS:C4287792


subject: UMLS:C4287792


subject: UMLS:C4287792


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Adult Solid Neoplasm


subject: CHEBI:5141

subject_name: Fomepizole

object_name: macular corneal dystrophy


subject: UMLS:C5446901

subject_name: CRL4-CRBN Modulator KPG-818

object_name: EXCESS LMW-DNA


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:4T36H88UA7

object_name: Stage III Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: Adenocarcinoma of the prostate stage III


subject: PUBCHEM.COMPOUND:44151801

object_name: Adenocarcinoma of the prostate stage IV


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: CHEBI:49662

subject_name: Indomethacin


subject: CHEBI:49662


subject: CHEBI:49662


subject: CHEBI:49662


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UNII:A7YT618XBV

subject_name: AS03 adjuvant

object_name: Klebsiella pneumoniae infection


subject: CHEBI:5062

subject_name: Finasteride

object_name: spinal cord injury


subject: CHEBI:5062

object_name: hypogonadism


subject: CHEBI:5062

object_name: spinal cord disorder


subject: CHEBI:5062

object_name: Wounds and Injuries


subject: CHEBI:5062

object_name: gonadal disease


subject: CHEBI:5062

object_name: CNS disorder


subject: CHEBI:5062

object_name: male reproductive system disorder


subject: CHEBI:5062

object_name: endocrine system disorder


subject: CHEBI:5062

object_name: nervous system disorder


subject: CHEBI:5062

object_name: nervous system injury


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: glioblastoma


subject: CHEBI:63635

object_name: Childhood Glioblastoma


subject: CHEBI:63635

object_name: adult glioblastoma


subject: UMLS:C5203423

subject_name: Nivolumab Liquid Injection

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:68564

subject_name: icatibant acetate

object_name: Surgical procedure finding


subject: CHEBI:68564

object_name: Inflammation


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant


subject: PUBCHEM.COMPOUND:71364


subject: UMLS:C0082926

subject_name: HOE 140


subject: UMLS:C0082926


subject: PUBCHEM.COMPOUND:91669168

subject_name: Zepatier

object_name: Chronic uremia


subject: CHEBI:132973


subject: RXCUI:1734632

subject_name: elbasvir / grazoprevir Oral Product


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: UNII:11Z5AIU653

subject_name: simtuzumab

object_name: interstitial lung disease 1


subject: UNII:11Z5AIU653

object_name: interstitial lung disease 2


subject: CHEMBL.COMPOUND:CHEMBL2109667

subject_name: SIMTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: UMLS:C2362561

subject_name: Gluten

object_name: fibromyalgia


subject: UMLS:C2827346

subject_name: wheat gluten extract


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: gastroesophageal cancer


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: Postoperative Nausea


subject: UMLS:C3715198

subject_name: Artemisia vulgaris whole extract

object_name: Hay fever


subject: DRUGBANK:DB14170

subject_name: Artemisia vulgaris root


subject: UMLS:C1443124

subject_name: Artemisia vulgaris allergenic extract


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Empty nose syndrome


subject: CHEBI:3160

object_name: atrophic rhinitis


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:4942

object_name: clear cell renal carcinoma


subject: GTOPDB:4942

object_name: renal cell adenocarcinoma


subject: GTOPDB:4942

object_name: renal cell carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human


subject: UMLS:C1610033


subject: UMLS:C1610033


subject: UMLS:C1610033


subject: UNII:UYE03B60KA

object_name: Ischemic stroke


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:231605

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:231605

object_name: Advanced renal cell carcinoma


subject: CHEBI:135953

subject_name: Bibrocathol

object_name: blepharitis


subject: CHEBI:135953

object_name: sign or symptom


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Arrhythmia


subject: UMLS:C2346810

object_name: adult hepatocellular carcinoma


subject: UMLS:C2346810

object_name: liver cancer


subject: UMLS:C2346810

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C2346810

object_name: liver carcinoma


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: UMLS:C5417947


subject: UNII:4180O0RM6K

object_name: HIV-1 infection


subject: UMLS:C5198160


subject: DRUGBANK:DB18189

subject_name: AGuIX

object_name: metastatic malignant neoplasm in the brain


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: acute myeloid leukemia


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: diabetes mellitus


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Brain fog


subject: UMLS:C1881373

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C1881373

object_name: Fatigue


subject: UMLS:C1881373

object_name: Thyroid dysfunction


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Menorrhagia


subject: CHEBI:63610

object_name: Menorrhagia, CTCAE


subject: CHEBI:41139

subject_name: BETAINE

object_name: Angelman syndrome


subject: CHEBI:41139

object_name: nervous system disorder


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: UMLS:C2825464

subject_name: metafolin


subject: UMLS:C2825464


subject: CHEBI:136009

subject_name: L-Methylfolate


subject: CHEBI:136009


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Carcinoma Unspecified Site


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Severe Sepsis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:136919716

object_name: Adverse Event Associated with Coagulation


subject: PUBCHEM.COMPOUND:136919716

object_name: Blood coagulation pathway observation


subject: UMLS:C4305751


subject: UMLS:C4305751


subject: CHEBI:36242

object_name: malnutrition


subject: CHEBI:36242

object_name: Presenile dementia


subject: CHEBI:36242

object_name: dementia


subject: CHEBI:36242

object_name: Mild dementia


subject: CHEBI:36242

object_name: Senile dementia


subject: CHEBI:36242

object_name: Moderate dementia


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: leukemia


subject: CHEBI:63605

object_name: childhood leukemia


subject: CHEBI:63605

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:63605

object_name: childhood germ cell tumor


subject: CHEBI:63605

object_name: Childhood Neuroblastoma


subject: CHEBI:63605

object_name: neuroblastoma


subject: CHEBI:63605

object_name: liver neoplasm


subject: CHEBI:63605

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:73151030

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:73151030

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: glioma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Sepsis


subject: CHEBI:6121

object_name: Sepsis, CTCAE


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:127342

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:127342

object_name: morbid obesity


subject: UNII:XG6DG6A1UN

subject_name: VONAFEXOR


subject: DRUGBANK:DB18782

subject_name: Vonafexor


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: milk allergy


subject: UMLS:C3658854


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:17061


subject: CHEBI:17061

object_name: fetal growth restriction


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:197107

subject_name: Bafetinib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: Machado-Joseph disease


subject: PUBCHEM.COMPOUND:71454399

subject_name: Venticute

object_name: pneumonia


subject: PUBCHEM.COMPOUND:71454399

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C1959272


subject: UMLS:C1959272


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: neoplasm


subject: UMLS:C1541378


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Reperfusion Injury


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Metastatic urothelial carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:03TW1410NL

object_name: type 2 diabetes mellitus


subject: UMLS:C0005525

subject_name: Biological Response Modifiers

object_name: cancer


subject: UMLS:C0005525


subject: UMLS:C0876248

subject_name: Immunotherapeutic agent


subject: UMLS:C0876248


subject: UMLS:C1513403

subject_name: Molecular Target


subject: UMLS:C1513403


subject: CHEBI:8499

subject_name: Propranolol

object_name: recurrent respiratory papillomatosis


subject: CHEBI:45615

subject_name: Salicylhydroxamic Acid

object_name: wet macular degeneration


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Inflammation


subject: CHEBI:6770

object_name: osteoporosis


subject: CHEBI:6770

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:6770

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:6770

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:6770


subject: CHEBI:6770

object_name: Diabetes


subject: CHEBI:6770

object_name: diabetes mellitus


subject: CHEBI:6770

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:6770

object_name: obesity


subject: CHEBI:6770

object_name: Obesity, CTCAE


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:45716

subject_name: Vorinostat

object_name: HIV-1 infection


subject: CHEBI:45716

object_name: infection; lymphoid tissue


subject: CHEBI:45716

object_name: Cd4+ Lymphocyte Deficiency


subject: UMLS:C0123759

object_name: Childhood Breast Carcinoma


subject: UMLS:C0123759

object_name: breast carcinoma


subject: UMLS:C0123759

object_name: breast cancer


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UNII:0AHT0IC02G

subject_name: FLOTETUZUMAB

object_name: acute myeloid leukemia by FAB classification


subject: UNII:0AHT0IC02G

object_name: acute myeloid leukemia


subject: UNII:0AHT0IC02G

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C3896731

subject_name: Flotetuzumab


subject: UMLS:C3896731


subject: UMLS:C3896731


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: Breastfeeding (mother)


subject: UMLS:C1831819

object_name: urinary bladder carcinoma


subject: UMLS:C1831819

object_name: urinary bladder cancer


subject: UMLS:C1831819

object_name: bladder tumor


subject: UMLS:C1831819

object_name: childhood bladder carcinoma


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: melanoma


subject: UMLS:C4764223

subject_name: Sustained-release Mitomycin C Hydrogel Formulation UGN-102


subject: UMLS:C4764223


subject: UMLS:C4764223


subject: UMLS:C4764223


subject: UMLS:C4764223

object_name: transitional cell carcinoma


subject: UMLS:C4764223

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:156963763

subject_name: Zoptarelin doxorubicin

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:156963763

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:156963763

object_name: endometrial carcinoma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: interstitial cystitis


subject: CHEBI:64816

object_name: Metastatic Lesion


subject: CHEBI:64816

object_name: neuroendocrine neoplasm


subject: CHEBI:64816

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:177770

subject_name: Ganetespib


subject: CHEMBL.COMPOUND:CHEMBL2108621

subject_name: MAPATUMUMAB

object_name: liver carcinoma


subject: UMLS:C1541394

subject_name: TRAIL-R1 mAb


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: CHEBI:63918

subject_name: Artesunate

object_name: hepatitis C


subject: CHEBI:18231

subject_name: arsenic acid


subject: UniProtKB:P0AF61

subject_name: GHOS_ECOLI Endoribonuclease antitoxin GhoS (sprot)


subject: PR:000002156


subject: PR:000006315

subject_name: protein artemis


subject: PR:000003846

subject_name: agouti-related protein


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:82960

subject_name: Raltegravir


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Critical Illness


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Emergence Delirium


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Post-Operative Pain


subject: CHEBI:7773


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: hypertension


subject: CHEBI:55438

object_name: Hypertension, CTCAE


subject: UMLS:C0103306


subject: UMLS:C0103306


subject: PR:000036013

subject_name: angiotensin 1-7


subject: PR:000036013


subject: CHEBI:90942

subject_name: Ixazomib

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:191852

subject_name: Ergmt

object_name: Meningitis caused by Enterovirus


subject: UMLS:C0009392

subject_name: Colony-Stimulating Factors


subject: PR:000005931


subject: UMLS:C0376561

subject_name: Recombinant Colony-Stimulating Factors


subject: CHEBI:85989

subject_name: Avycaz

object_name: kidney failure


subject: CHEBI:85989

object_name: Renal Failure, CTCAE


subject: CHEBI:85989

object_name: bacterial infectious disease


subject: CHEBI:85989


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: CHEBI:61080

subject_name: Romidepsin

object_name: melanoma


subject: UMLS:C4082795

subject_name: Depsipeptide Antineoplastic Antibiotic


subject: UMLS:C0963679


subject: UMLS:C0796678

subject_name: Depsipeptides


subject: CHEBI:38108

subject_name: azetidine-2-carboxylic acid

object_name: adult acute myeloid leukemia


subject: CHEBI:38108

object_name: childhood acute myeloid leukemia


subject: CHEBI:38108

object_name: acute myeloid leukemia


subject: UMLS:C3641717

subject_name: SUBA-itraconazole

object_name: ovarian cancer


subject: UMLS:C3641717

object_name: ovarian neoplasm


subject: UMLS:C3641717

object_name: ovarian carcinoma


subject: CHEBI:23965

subject_name: estradiol

object_name: thrombophilia


subject: UMLS:C1337396

subject_name: minocycline HCl microspheres

object_name: periodontitis


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Cannabis use disorder


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: Stomach cancer


subject: UMLS:C5667079

object_name: gastric cancer


subject: UMLS:C5667079

object_name: carcinoma of esophagus


subject: UMLS:C5667079

object_name: esophageal cancer


subject: UMLS:C5667079

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5667079

object_name: neoplasm of esophagus


subject: UMLS:C5667079

object_name: colorectal cancer


subject: UMLS:C5667079

object_name: colorectal carcinoma


subject: UMLS:C5667079

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5555042

subject_name: Danvilostomig


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C5555042


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Myelodysplasia


subject: UMLS:C1145201

object_name: leukemia


subject: UMLS:C1145201

object_name: childhood leukemia


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:309594

subject_name: Oxybuprocaine

object_name: retinopathy of prematurity


subject: CHEBI:309594

object_name: exudative vitreoretinopathy 1


subject: CHEBI:309594

object_name: Retinopathy of Prematurity, AE


subject: UMLS:C0003921

subject_name: artificial tears (medication)


subject: UMLS:C0003921


subject: UMLS:C0003921


subject: UMLS:C2608262

subject_name: Lubricant Eye Drops


subject: UMLS:C2608262


subject: UMLS:C2608262


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline


subject: UMLS:C1154269


subject: UMLS:C1154269


subject: CHEMBL.COMPOUND:CHEMBL3545020

object_name: type 2 diabetes mellitus


subject: UNII:1G26B32139

subject_name: Pumosetrag

object_name: Heartburn


subject: UNII:1G26B32139

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: mucosal melanoma


subject: UMLS:C0499161

object_name: Sinonasal Mucosal Melanoma


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: shigellosis


subject: CHEBI:16302

object_name: Premature birth


subject: CHEBI:12777

subject_name: Vitamin A


subject: UNII:G9C7884M8M

object_name: HIV infection


subject: UNII:638KY4573I

object_name: essential hypertension


subject: PUBCHEM.COMPOUND:20285768

subject_name: 3-Aminobutane-1-sulfonic acid


subject: UMLS:C2733644

subject_name: Black Seed Oil

object_name: asthma


subject: CHEBI:174348

object_name: Primary dysmenorrhea


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: CHEBI:44915

subject_name: Propofol

object_name: migraine


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency


subject: CHEBI:17650

object_name: adrenogenital syndrome


subject: CHEBI:17650

object_name: congenital adrenal hyperplasia


subject: CHEBI:16962

subject_name: Cortisone


subject: CHEBI:16962


subject: CHEBI:16962


subject: CHEMBL.COMPOUND:CHEMBL4300244

subject_name: SAMARIUM

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4300244

object_name: prostate cancer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Myocardial injury


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: melioidosis


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: periodontal disorder


subject: CHEBI:8869

object_name: periodontitis


subject: CHEBI:8869

object_name: Periodontal Disease, CTCAE


subject: PUBCHEM.COMPOUND:86294067

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: acute myeloid leukemia


subject: UNII:OJE5810C4F

subject_name: Taxoprexin

object_name: non-small cell lung carcinoma


subject: UMLS:C1135143


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Resectable non-small cell lung cancer


subject: UMLS:C5557492

object_name: refractory malignant neoplasm


subject: UMLS:C5557492

object_name: Advanced cancer


subject: UMLS:C5557492

object_name: gastric neoplasm


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:6801

subject_name: Metformin

object_name: Post transplant diabetes mellitus


subject: CHEBI:6801

object_name: New onset diabetes after transplantation


subject: CHEBI:6801

object_name: New Onset Diabetes After Transplant


subject: CHEBI:6801

object_name: Disorder of transplanted kidney


subject: CHEBI:6801

object_name: end stage renal failure


subject: CHEBI:6801

object_name: Chronic uremia


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:71954

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: brain cancer


subject: CHEBI:132268

object_name: brain neoplasm